is a broadly expressed transporter of prostaglandins (PGs) and thromboxane that is energetically poised to take up prostanoids across the plasma membrane. To gain insight into the function of PGT, we generated mouse monoclonal antibody 20 against a portion of putative extracellular loop 5 of rat PGT. Immunoblots of endogenous PGT in rat kidney revealed a 65-kDa protein in a zonal pattern corresponding to PG synthesis rates (papilla Х medulla Ͼ cortex). Immunocytochemically, PGT in rat kidneys was expressed in glomerular endothelial and mesangial cells, arteriolar endothelial and muscularis cells, principal cells of the collecting duct, medullary interstitial cells, medullary vasa rectae endothelia, and papillary surface epithelium. Proximal tubules, which are known to take up and metabolize PGs, were negative. Immunoblotting and immunocytochemistry revealed that rat platelets also express abundant PGT. Coexpression of the PG synthesis apparatus (cyclooxygenase) and PGT by the same cell suggests that prostanoids may undergo release and reuptake. carrier proteins; biological transport; molecular cloning PROSTAGLANDINS (PGS) AND THROMBOXANES (Txs) play fundamental roles in context-dependent autocrine and paracrine signaling. In the kidney, for example, depending on the site of release and the receptors activated, PGE 2 vasodilates or vasoconstricts blood vessels, stimulates renin release, and modulates Na, Cl, and water transport (24).
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The kidney exemplifies the principle that prostanoid synthesis and degradation are compartmentalized into separate cell types and tissue zones. Regionally, the highest rates of renal PG synthesis occur in the papilla. Renal cell types that synthesize PGs and/or express cyclooxygenases (COXs) include glomerular mesangial cells and endothelia, collecting ducts, and medullary interstitial cells (24) . In contrast, renal oxidation of PGs occurs in the cortex and juxtamedullary regions (24, 32) , primarily by means of the proximal straight tubule, which actively secretes both native and oxidized PGs (13, 16) .
Our laboratory recently identified a rat cDNA encoding PGT, the first known PG transporter. When expressed heterologously in cultured cells or Xenopus laevis oocytes, PGT mediates the uptake of PGE 2 and TxB 2 , among other eicosanoids (17, 21) . The broad expression pattern of PGT mRNA in rats, humans, and mice (17, 21, 28) has suggested a possible physiological role in the release of newly synthesized prostanoids and/or PG uptake before intracellular oxidation (32) .
To further explore the physiological role of this transporter, we have immunolocalized PGT in rat kidneys and have also sought evidence for PGT expression in rat platelets, which synthesize and release TxA 2 (1).
MATERIALS AND METHODS
Generation of monoclonal antibody 20 against rat PGT. We PCR-amplified a portion of the rat PGT (rPGT) cDNA corresponding to deduced amino acids 430-505 on putative exofacial loop 5 and cloned it into the vector pGEX to generate an rPGT-glutathione S-transferase (GST) fusion protein. Mice were immunized with the purified fusion protein, myeloma fusions were performed by using the standard Kohler-Milstein approach (20) , and hybridomas were screened by ELISA by using the fusion peptide vs. GST alone. Of several monoclonal antibodies generated, mouse monoclonal antibody 20 (MAb20) of the class IgG1 was expanded for use.
Transient expression of PGT cDNAs and determination of tracer PGE 2 uptake. HeLa cells, grown to 70-80% confluence on 35-mm dishes, were infected with recombinant vaccinia virus vTF7-3 (10 plaque-forming units/cell) as described previously (17) . Cells were then transfected with 10 g of full-length rPGT. The transfection medium was removed after 3 h, and the cells were incubated for an additional 20-26 h at 37°C in culture media (DMEM with 10% fetal bovine serum and antibiotics).
Tracer PG uptakes were performed as previously described (17) . Briefly, after the cell monolayers were washed twice with Waymouth solution, timed uptake was begun by changing to Waymouth solution containing [ 3 H]PGE2 (171 Ci/ mmol; DuPont-New England Nuclear, Boston, MA) at a final concentration of 0.1 Ci/ml (0.6 nM PGE 2). Uptake was terminated by aspirating the uptake medium and washing the cell monolayers twice with ice-cold Waymouth solution containing 5% bovine serum albumin and twice with ice-cold unaltered Waymouth solution. Cells were scraped and suspended in 1 ml of Waymouth solution, which was then added to 10 ml of scintillation fluid for determination of radioactive counts by liquid scintillation spectrophotometry.
In separate experiments, water or in vitro transcribed and capped rPGT cRNA was injected into X. laevis oocytes (50 ng mRNA/oocyte), and uptake of [ 3 H]PGE2 was determined 3 days after injection to confirm expression (11) .
Immunocytochemistry and immunoblotting of heterologously expressed rPGT. For immunocytochemistry, HeLa cells seeded onto glass coverslips were transiently transfected with rPGT as described in Transient expression of PGT cDNAs and determination of tracer PGE 2 uptake and were then fixed in 2% paraformaldehyde for 60 min. After being blocked with 5% goat serum, cells were incubated with MAb20 as the supernatant at 4°C overnight, followed by incubation with FITC-coupled goat anti-mouse IgG. Fluorescence was visualized with a Bio-Rad MRC 600 laser scanning confocal microscope.
For immunoblotting, 10 water-injected control X. laevis oocytes and 10 rPGT-expressing oocytes (confirmed by tracer PGE 2 uptake as described in Transient expression of PGT cDNAs and determination of tracer PGE2 uptake) were extracted with Triton X-100 (0.5%, 10 min, 4°C) and centrifuged at 12,000 g for 10 min. Equivalent aliquots of supernatant were subjected to SDS-PAGE electrophoresis. Proteins were electrophoretically transferred to nitrocellulose membranes, blocked in 5% nonfat milk, and immunoblotted with MAb20. In separate experiments, rPGT was transiently expressed in HeLa cells as described in Transient expression of PGT cDNAs and determination of tracer PGE2 uptake, and the cells were scraped into protease inhibitors and subjected to SDS-PAGE, followed by transfer and immunoblotting with MAb20. Primary antibody was added as the undiluted hybridoma supernatant; the secondary antibody was horseradish peroxidase-coupled rabbit anti-mouse IgG (Cappel, Westchester, PA). Bands were visualized by enhanced chemiluminescence (Amersham).
Immunocytochemistry and immunoblotting of endogenous rPGT in rat kidney. Kidney immunocytochemistry was performed in one of three ways. In each case, male SpragueDawley rats were anesthetized with Nembutal.
In some experiments, rat kidneys were perfusion fixed. After the kidneys were perfused free of blood with heparinized saline, they were perfused with 2% paraformaldehyde for 2-5 min at 27°C, cut into coronal sections, and immersion fixed overnight in 2% paraformaldehyde at 4°C. Vibratome sections (50 m) were cut and incubated in PBS for 1-2 days at 4°C with daily changes, then blocked in 5-10% goat serum, incubated in MAb20 (as hybridoma supernatant) overnight at 4°C, washed, and incubated in FITC-coupled goat anti-mouse IgG.
For ultrastructural kidney localization, vibratome sections generated as described above were blocked for 2 h in 5% nonfat milk, incubated overnight in MAb20 and then for 2 h in goat anti-mouse IgG coupled to 20-nm gold (EY Laboratories), and washed, after which the gold was silver enhanced for 5-15 min (Vector Laboratories, Burlingame, CA).
In separate experiments, unfixed rat kidneys were frozen, and 5-m cryosections were cut onto glass slides, fixed with 0.5% paraformaldehyde for 30 min at 27°C, and washed and labeled as above. Sections were visualized by confocal microscopy.
Carbonic anhydrase type II was visualized in rat kidneys with a rabbit polyclonal antibody (7, 9), followed by visualization with a rhodamine-coupled goat anti-rabbit IgG. COX-1 was visualized by using a mouse monoclonal antibody of the IgG2b class (Oxford Biomedical Research) followed by a type-specific rhodamine-coupled goat anti-mouse secondary antibody (Fisher, Hampton, NH). In this case, MAb20 was visualized by using an FITC-coupled goat anti-mouse IgG1-specific antibody (Vector Laboratories). COX-2 was visualized by using an anti-sheep goat polyclonal antibody (Cayman Chemical, Ann Arbor, MI). Von Willibrand factor (vWF) was detected by using a rabbit anti-human vWF antibody (Dako, Carpinteria, CA) followed by a lissamine rhodaminecoupled goat anti-rabbit immunoglobulin. Synaptopodin was detected by using a rabbit polyclonal antibody that was courtesy of Dr. Peter Mundel (27) .
For immunoblots of endogenous rPGT in kidney, rats were anesthetized, their kidneys were perfused with heparin and homogenization buffer (0.32 M sucrose, 5 mM Tris ⅐ HCl, 2 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 1 g/ml pepstatin), removed, and cut into coronal slices, which were further cut into cortical, medullary, and papillary zones. Pooled samples were pulverized by using a liquid nitrogen mortar and pestle and scraped into homogenization buffer, and 20 g protein/lane were subjected to SDS-PAGE electrophoresis and immunoblotting as described in Immunocytochemistry and immunoblotting of heterologously expressed rPGT for heterologous expression of PGT in HeLa cells. Band densities were quantified from radiographs by scanning and measuring pixel intensities with Adobe Photoshop.
Immunoblotting and immunocytochemistry of rPGT in rat platelets. Blood was harvested from the abdominal vena cava of anesthetized rats, dripped into a polypropylene tube containing 0.372 ml of 10% EDTA, and centrifuged at 200 g for 15 min at 21°C, and the platelet-rich plasma (PRP) was pipetted off. Column purification of PRP was performed by applying PRP to a running Sepharose 2B column at 21°C as described previously (29, 33) .
For platelet immunocytochemistry, washed platelets (ϳ4 ϫ10 5 /l) were equilibrated at 37°C, and aliquots were incubated with or without thrombin (2.5 U/ml) for 1 min, pelleted by centrifugation (2,000 g), and resuspended in 50 l wash buffer. They were then dispersed in liquefied 10% gelatin. After solidification on ice, the gelatin blocks were embedded in OCT and stored at Ϫ80°C. Thereafter, 5-m cryosections were cut, thawed onto glass coverslips, and fixed in 0.5% paraformaldyde for 1 h. After an overnight rinsing in PBS at 4°C, the sections were exposed to MAb20, followed by exposure to an FITC-coupled secondary antibody.
For immunoblots of endogenous PGT in rat platelets, protein lysates from washed rat platelets were separated by SDS-PAGE, transferred to nitrocellulose membranes, probed with MAb20 followed by a horseradish peroxidase-coupled secondary antibody, and visualized using chemiluminescence.
RESULTS

Validation of anti-rPGT antibody.
We first set out to validate mouse MAb20 by showing that it can recognize the rPGT holoprotein immunocytochemically in fixed cells and also when PGT is subjected to immunoblotting. We used HeLa cells and X. laevis oocytes because our laboratory has previously shown that these cell types have a low level of background PG transport and also express heterologous PGT well (11, 17) . HeLa cells were transiently transfected with full-length cDNAs encoding rPGT. After expression of the transporter at the plasma membrane was confirmed by tracer PGE 2 uptake (data not shown) (17) , the cells were examined immunocytochemically. Mouse MAb20 recognized rPGT at the plasma membrane (Fig. 1A , arrows) as well as in an intracellular compartment that probably represents the Golgi apparatus.
X. laevis oocytes were injected with water or cRNA encoding rPGT, and the membranes were extracted with Triton X-100, subjected to SDS-PAGE under nonreducing conditions, and immunoblotted with MAb20 (Fig. 1B) . The strong immunoreactive band at 68 kDa (Fig. 1B, lane 1) , corresponding to the predicted PGT molecular mass of 68 kDa, was not seen in control (water-injected) oocytes (Fig. 1B, lanes 2 and 4) , or when the hybridoma supernatant was preabsorbed with the fusion peptide (Fig. 1B, lanes 3 and 4) .
Separately, HeLa cell monolayers transiently transfected with rPGT were immunoblotted with MAb20 under both reducing and nonreducing conditions. Similar to oocytes, mAb20 recognized a 65-kDa immunoreactive band (Fig. 1C, lane 2) that was not present after transfection with the vector control (Fig. 1C, lane 1) .
Immunoreactivity was abrogated by including the immunogen peptide or when the reducing agent dithiothreitol was used (data not shown). The latter finding is consistent with our modeling of the immunogenic region, a region rich in cysteine residues, as being extracytoplasmic and thus structurally defined by means of disulfide bonds (32) .
Immunological characterization of PGT in rat kidneys. On the basis of the hypothesis that insights into PGT function could be gained by knowing the cell types in which it is expressed, rat kidneys were sectioned into zones and probed by immunoblotting. Figure 2A shows that MAb20 recognizes an immunoreactive band of 65 kDa in rat kidney with the zonal distribution cortex (C) Ͻ medulla (M) Х papilla (P). Quantitation on two separate blots showed that the PGT band revealed 5.6 average densitometry units of cortex, 8.1 of medulla, and 9.7 of papilla. Adsorption of MAb20 with the immunogen abrogated immunoreactivity (data not shown).
We next probed rat kidney immunocytochemically for PGT expression by using several complementary methods. Perfusion fixation gives better overall tissue Fig. 2 . Expression of endogenous PGT in rat kidney zones. A: rat kidney was divided by hand into cortex (C), medulla (M), and papilla (P), and these zones were subjected to SDS-PAGE and immunoblotting with MAb20. B: 50-m coronal cryosections of kidney were cut and labeled with MAb20 hybridoma supernatant (left) or with mAb20 supernatant that had been preadsorbed with the immunogen (right). Detection was by the peroxidase method.
preservation than cryosectioning, because the tissue is well penetrated by fixative and sectioning with a vibratome leaves a substantial core of central material undamaged by the knife. However, because the fixative concentration is highest in the vascular lumen, this method can result in false-negative vascular immunolocalization, especially when monoclonal antibodies are used, if that epitope happens to be easily denatured by fixation. Therefore, we used a combination of perfusion fixation for light and ultrastructural labeling, and we also used light-level cryosectioning to capture all possible PGT immunoreactivity. Figure 2B shows a whole-kidney "zonal" approach similar to that taken above with the immunoblot. A 50-m cryosection of whole rat kidney was labeled immunocytochemically with MAb20. As with the immunoblot, this low-power view reveals that the kidney cortex has relatively sparse overall PGT protein labeling, whereas the medulla and papilla demonstrate more pronounced, and roughly equivalent, PGT labeling intensities. Figure 3 shows MAb20-labeled rat renal vascular structures in cryosectioned tissue (Fig. 3, A-H) . Figure  3A shows MAb20-labeled glomeruli in a possible nuclear or perinuclear labeling pattern. Some glomerular regions were positive for the endothelial marker vWF (Fig. 3B) . Double labeling revealed that these regions coexpress PGT and vWF (Fig. 3C) , indicating that PGT is expressed in glomerular endothelial cells.
Glomerular cells devoid of vWF expression were also labeled with MAb20 (Fig. 3C, green) ; these could represent either mesangial cells or podocytes. Glomerular podocytes selectively express synaptopodin (27) . Double labeling for PGT with MAb20 (Fig. 3D) and a rabbit polyclonal anti-synaptopodin antibody (Fig. 3E) revealed that podocytes do not express PGT (Fig. 3F) . Therefore, by elimination, the cells in Fig. 3C that were positive for PGT but negative for vWF appear to be mesangial cells.
PGT expression was also observed in adjacent renal cortical arterioles (Fig. 3G) . Double labeling for vWF demonstrates PGT expression in both the endothelial ; E) , and the merging of images D and E (F). F: lack of yellow-labeled cells indicates that PGT is not expressed in podocytes. G and H: low-power view of rat kidney cortex. Arrows, glomeruli fed by arterioles; *, an isolated arteriole. Labeling for PGT alone (G) and double-labeling for vWF (endothelia; H) reveal that PGT is expressed in arteriolar endothelia (yellow label in the 2 arterioles leading into the glomeruli and in the arteriole at bottom left) and in the muscularis layer (green label outside of the yellow regions in the arterioles). I: transmission electron micrograph of rat kidney labeled for PGT by the preembedding immunogold method. An outer medullary vasa recta endothelial cell body is shown with gold particles in the cytoplasm (presumably vesicular) and at the plasma membrane (arrows).
layer (coexpression with vWF) and the muscularis layer (Fig. 3H) . PGT could be visualized ultrastructurally in medullary vasa rectae cell bodies in the cytoplasm and at the plasma membrane (Fig. 3I) .
Perfusion-fixation methods also revealed PGT expression in nonvascular structures. Figure 4A shows a representative cortical collecting duct in which PGT is expressed in what appear to be subapical vesicles in some, but not all, cells. In contrast to the case with vasa rectae, ultrastructural examination revealed no expression at the plasma membrane in collecting duct cells (data not shown). The PGT-positive cells are principal cells, as shown by double labeling for PGT and the intercalated cell-specific enzyme carbonic anhydrase II (Fig. 4B) (18, 31) . Indeed, PGT is expressed in cytoplasmic vesicles along the collecting duct, including the outer medullary and papillary segments (Fig. 4C) . The papillary surface epithelium also expressed a strong pattern of vesicular PGT (not shown). Medullary interstitial cells of the initial portion of the inner medulla also express PGT in cytoplasmic vesicles. Double labeling revealed that these cells express PG endoperoxide H synthase-1 (Fig. 4D) .
Immunocytochemistry using anti-COX-2 antisera revealed weak labeling of both macula densa and medullary interstitial cells, as expected in rats on a controlled-sodium diet (37) . There was no colocalization between PGT and COX-2 in the macula densa, whereas PGT did colocalize with COX-2 in interstitial cells in a pattern indistinguishable from that of COX-1 (data not shown).
The proximal tubules of rat kidney were negative in all of these studies. We also used other fixation regimens, such as periodate-lysine-paraformaldehyde (25) and "antigen retrieval" with detergents (30); none of these methods revealed labeling of the proximal tubule (data not shown).
Immunological characterization of PGT in rat platelets. The results in rat kidney suggest that PGT expression is confined to cell types that synthesize and release PGs. To test this hypothesis further, we turned to rat platelets, a readily available cell that synthesizes Tx. Figure 5A , top, shows that rat platelets embedded in gelatin express strong PGT expression by fluorescence immunocytochemistry. This labeling is abolished when the PGT-GST fusion peptide is mixed with mAb20 (Fig. 5A, bottom) . Addition of thrombin before gelatin embedding causes platelet aggregation (Fig.  5A, right) . It is unclear whether the apparent increase in fluorescence intensity after thrombin addition (Fig.  5A, top) can be ascribed to either aggregation or unmasking of PGT epitope(s), or both.
On immunoblots of rat platelets, MAb20 recognized a band of 65 kDa that comigrates with rPGT heterologously expressed in HeLa cells (68 kDa), which was adsorbed out almost completely with the GST-PGT fusion peptide (Fig. 5B) .
DISCUSSION
We have generated a monoclonal antibody (MAb20) against a putative extracytoplasmic loop of rPGT. We validated the ability of the antibody to recognize the intact transporter by using heterologous expression in cultured cells and X. laevis oocytes. When used to probe for endogenous PGT expression in kidneys and platelets, this antibody revealed that the pattern of PGT expression by kidney zones (papilla Х medulla Ͼ cortex) and in distinct kidney cell types correlates with known PG synthesis, including glomerular endothelial and mesangial cells, cortical arteriolar endothelium and muscularis, collecting ducts, and medullary interstitial cells and vasa rectae. Further immunological studies indicated that PGT is strongly expressed in rat platelets. In contrast, the proximal straight tubule, which is known to take up, oxidize, and secrete PGs in a process of metabolic clearance, does not express PGT.
Topper et al. (34) reported that antisera against the COOH terminus of human PGT labeled endothelia, but not other structures, in the human kidney, results which vary from the present data. In addition to recognizing PGT in endothelia, our anti-rat mAb20 also recognizes immunoreactivity in glomerular mesangial cells, arteriolar muscularis layers, collecting ducts, medullary interstitial cells, and papillary surface epithelia. Differences in fixation technique may account for the variation in labeling between our work and that of Topper et al., because we found glomerular and cortical arteriolar labeling to be strongest in cryosections, whereas tubular and interstitial cell labeling was best obtained with perfusion fixation. In addition, species differences in expression may play a role. Finally, the human PGT gene structure suggests that multiple protein isoforms might arise by means of alternative splicing (23) . Thus it is possible that different domains of the transporter are expressed in different tissues and might be recognized variably by antisera against differing protein domains.
Although PGT is expressed at the plasma membrane of medullary vasa recta cells, in collecting duct and medullary interstitial cells it is expressed in cytoplasmic vesicles. Nonetheless, we hypothesize that PGT can be recruited to the plasma membrane by means of exocytic-endocytic cycling, as is the case with many other plasma membrane transporters, such as sodium channels and glucose transporters (6, 8) . In support of this hypothesis, we have shown in companion experiments that green fluorescence protein-tagged rPGT is sorted in Madin-Darby canine kidney cells to the apical plasma membrane, where it mediates active uptake and transepithelial PG resorption (12) . Further experiments will be required to delineate the stimuli, if any, that could induce exocytic insertion into the plasma membrane in collecting duct and medullary interstitial cells.
The glomerular labeling for PGT shows a possible nuclear or perinuclear labeling pattern. Although this is most likely due to a shift of antigen during fixation (26), we cannot exclude the possibility that PGT in glomeruli is expressed in a different cellular compartment than that in tubules, endothelia, and interstitial cells. If this is the case, it could indicate multiple functions for the transporter, depending on cell type.
On the basis of its broad expression, we previously postulated that PGT might play a role in the metabolic clearance and/or release of PGs (32) . The present results help us to better consider these possibilities.
The lack of PGT expression in the proximal tubule argues strongly against a role in the known metabolic clearance of PGs by this nephron segment (32) . Presumably, uptake of PGs by the proximal tubule is mediated by any of several organic anion transporters identified recently, some of which have been shown to be expressed at the proximal tubule basolateral membrane (35) .
The present data show that PGT expression is limited to cells that synthesize and release PGs. Indeed, we have shown in recent preliminary studies that COX-2 and PGT are coordinately induced by serum in Swiss 3T3 cells (22) . Because PGs efflux readily from cells by simple diffusion (11) and because PGT is coupled to glycolysis to be energetically poised for PG uptake (10) , it seems unlikely that PGT directly mediates the release of newly synthesized prostanoids.
Instead, we speculate that PGT at the plasma membrane mediates PG reuptake. Such a model might be Fig. 5 . Expression of PGT in rat platelets. A: fluorescence immunocytochemistry of rat platelets embedded in gelatin. Platelets were not exposed to thrombin (left) or were induced to aggregate by exposure to thrombin (2.5 U/ml) for 1 min (right). Bottom: MAb20 was preadsorbed with the immunizing peptide. B: immunoblot of endogenous PGT in rat platelets (plts) compared with recombinant rPGT heterologously expressed in HeLa cells (left). Single immunoreactive band is recognized by MAb20 in both lanes. Right: MAb20 was preadsorbed with the immunogen, i.e., the PGT-glutathione S-transferase fusion protein.
similar to that of synaptic signaling, in which the secreted neurotransmitter is taken up by the cell that released it and also by other cell types. In the brain, ␥-aminobutyric acid is cleared from the synaptic cleft by specific, high-affinity Na-and Cl-dependent transporters located on both presynaptic terminals and surrounding glial cells (5) . In the retina, glutamate is released by photoreceptor cells and is taken up by glutamate transporters expressed on both photoreceptor cells and Muller cells (36) .
In the case of PGs, we propose that efflux would occur by unregulated simple diffusion (11) . In the presence of an outwardly directed lactate gradient from aerobic glycolysis [for example, in collecting ducts (2, 15) ], PGT would be poised to take PGs back into the cytoplasm. PG reuptake might 1) control net release either as a negative-feedback loop when PG synthesis is stimulated or in quiescent cells to minimize "leak" of basal PGs or 2) signal intracellular events using pathways separate from cell-surface prostanoid receptors, e.g., by binding to prostanoid receptors expressed on the nuclear envelope (3, 4) or to peroxisome proliferator activator receptors in the nucleus (14, 19) . Testing of these models will require further experiments.
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